Ads
related to: depuy hip replacement recalls
Search results
Results from the WOW.Com Content Network
The 2010 DePuy Hip Replacement Recall was instituted when DePuy Orthopaedics, Inc., a division of Johnson and Johnson, recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010.
In August 2010, DePuy recalled its hip replacement systems ASR XL Acetabular Hip Replacement System and ASR Hip Resurfacing System due to failure rates and side effects including metallosis. The recalls triggered a large number of lawsuits against DePuy and its parent company Johnson & Johnson upon claims that the companies knew about the ...
On August 24, 2010, DePuy recalled all ASR hip implant systems sold since 2003. The 2010 DePuy Hip Recall was issued after research released by the National Joint Registry (NJR) found high rates of hip replacement failure for the ASR XL Acetabular and ASR Hip Resurfacing systems.
The other product, the Corail Hip System, was cleared, the FDA says, and indicated for cementless use only. But the company marketed the hip replacement for two unapproved uses, as mentioned in ...
The recall affects batches Johnson & Johnson (NYS: JNJ) has announced its latest recall. This time, the recall involves about 200,000 syringes of its Eprex anemia drug, since some batches may not ...
On August 24, 2010, DePuy, a subsidiary of American giant Johnson & Johnson, recalled its ASR (articular surface replacement) hip prostheses from the market. DePuy said the recall was due to unpublished National Joint Registry data showing a 12% revision rate for resurfacing at five years and an ASR XL revision rate of 13%. All hip prostheses ...
(Reuters) - New diabetes and weight-loss drugs may benefit patients undergoing hip replacement, without adding to complication risks, according to preliminary data released on Monday at a large...
2010 DePuy Hip Recall; Abductor wedge; Femoroacetabular impingement; Gruen zone; Hip examination; References
In 2010, the ASR device (produced by DePuy, also a metal-on-metal resurfacing implant) was recalled, and resulted in many cases of litigation.
Johnson & Johnson (JNJ) has issued another recall, and this time, it's not over a typo. The company's Animas unit recalled five lots of leaking insulin cartridges that could lead to serious health ...